SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0002018119-24-000003
Filing Date
2024-04-05
Accepted
2024-04-05 19:11:00
Documents
3
Period of Report
2024-04-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1712358651.html 3  
1 FORM 3 wk-form3_1712358651.xml 3 6782
2 EX-24 powerofattorneyulrich.htm EX-24 632
3 powerofattorneyulrich001.jpg GRAPHIC 152315
  Complete submission text file 0002018119-24-000003.txt   218969
Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Issuer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ALPINE IMMUNE SCIENCES, INC. 185 EAST BLAINE STREET, SUITE 200 SEATTLE WA 98102
Business Address
FUHS ULRICH MARTIN (Reporting) CIK: 0002018119 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37449 | Film No.: 24827819